ADC Therapeutics SA (ADCT) Profit Margins
Over the twelve months to 2026-06-30, ADC Therapeutics SA (ADCT) had operating margin -125.1%, net margin -121.8%, free cash flow margin -128.5%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ADCTADC Therapeutics SAFollow ADCT — free
—
Price chart with a free account
- Market cap
- 183.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Gross margin | 96.4% | 91.6% | 92.9% | — | |
| Operating margin | -238.6% | -184.4% | -149.3% | -125.1% | |
| Net margin | -345.1% | -222.8% | -175.3% | -121.8% | |
| FCF margin | -175.3% | -176.0% | -173.8% | -128.5% |
USD millions · SEC XBRL
ADC Therapeutics SA — questions
- What is ADC Therapeutics SA's operating margin?
- -125.1% over the twelve months to 2026-06-30.
- What is ADC Therapeutics SA's net profit margin?
- -121.8% over the twelve months to 2026-06-30.
Every figure on this page comes from ADC Therapeutics SA's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.